Interacting Drugs |
Natalizumab vs Immunosuppressants |
Security Level |
|
Mechanism |
Immunosuppressants: May enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased. Exceptions: Cytarabine (Liposomal). |
Management |
Avoid combination |
Natalizumab vs Immunosuppressants
Post Review about Natalizumab vs Immunosuppressants Click here to cancel reply.
Other Interactions of Natalizumab
Other Interactions of Immunosuppressants
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.